What Is the Value of a Food and Drug Administration Investigational New Drug Application for Fecal Microbiota Transplantation to Treat Clostridium difficile Infection?

Gail Hecht, Martin J. Blaser, Jeffrey I. Gordon, Lee M. Kaplan, Rob Knight, Loren Laine, Richard M. Peek, Mary Ellen Sanders, Balfour R. Sartor, Gary D. Wu, Vincent W. YangClinical 2013 · DOI · OpenAlex

BibTeX
@inproceedings{hecht2013what,
  author = {Gail Hecht and Martin J. Blaser and Jeffrey I. Gordon and Lee M. Kaplan and Rob Knight and Loren Laine and Richard M. Peek and Mary Ellen Sanders and Balfour R. Sartor and Gary D. Wu and Vincent W. Yang},
  title = {{What Is the Value of a Food and Drug Administration Investigational New Drug Application for Fecal Microbiota Transplantation to Treat Clostridium difficile Infection?}},
  booktitle = {Clinical},
  year = {2013},
  doi = {10.1016/j.cgh.2013.10.009},
}

Loading related content...

Figure